Can we readily identify patients who need antibiotics in a severe influenza pandemic?

Medical Journal of Australia

Volumn 191, Issue 9, 2009, Pages 517-518

  Charles, Patrick G P ^a   Johnson, Paul D R ^a   Collignon, Peter J ^b  

^a AUSTIN HEALTH   (Australia)

^b CANBERRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

BACTERIAL PNEUMONIA; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; LETTER; PANDEMIC; VIRUS STRAIN; ADULT; AGE; AGED; COMMUNICABLE DISEASE; EMERGENCY HEALTH SERVICE; EPIDEMIC; FEMALE; HOSPITALIZATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DISEASE OUTBREAKS; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TRIAGE;

EID: 73349126737     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2009.tb02922.x     Document Type: Letter

References (6)

1. World Health Organization. Pandemic (H1N1) 2009 - update 60. http://www.who.int/csr/don/2009-08-04/en/index.html (accessed Aug 2009).
2. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008; 198: 962-970.
3. Brundage JF, Shanks GD. Deaths from bacterial pneumonia during 1918-1919 influenza pandemic. Emerg Infect Dis 2008; 14: 1193-1199.
4. Australian Government Department of Health and Ageing. Resource - clinical management of pandemic (H1N1) 2009. http://www.public.health.wa.gov.au/ cproot/2382/2/090709%20Clinical%20Resource%20H1N1%2009%20-%20FINALGDL.pdf (accessed Sep 2009).
5. Charles PG, Whitby M, Fuller AJ, et al. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin Infect Dis 2008; 46: 1513-1521. (Pubitemid 351706731)
6. Charles PG, Wolfe R, Whitby M, et al. SMART-COP: a tool for predicting need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 2008; 47: 375-384. (Pubitemid 352009359)